Background Image
Table of Contents Table of Contents
Previous Page  32 / 64 Next Page
Information
Show Menu
Previous Page 32 / 64 Next Page
Page Background

CARDIOVASCULAR JOURNAL OF AFRICA • Volume 30, No 4, July/August 2019

218

AFRICA

There was a positive correlation between RV free-wall PSS

and LVGLS in patients with CRMR (

r

=

0.3,

p

<

0.001). The

majority of patients (45%) had preserved RV free-wall PSS and

LVGLS, 26% had decreased LVGLS and RV free-wall PSS, 18%

had diminished LVGLS and preserved RV free-wall PSS, and a

minority (11%) had preserved LVGLS with decreased RV free-

wall PSS (Fig. 2).

By univariate linear regression analysis, severe MR, grade

2+ TR, PASP, LVEF, LV end-diastolic diameter, lateral S

and LVGLS showed a significant association with RV free-wall

PSS, with LVGLS having the strongest correlation (Table 5). By

multivariate linear regression analysis after adjusting for age

and gender, LVGLS and grade

2+ TR emerged as the most

important predictors of RVPSS (Table 5).

RV free-wall PSS measurements were feasible in 76 patients.

In one patient, RV free-wall PSS was not feasible due to poor

imaging of the lateral wall, however, LVGLS could be quantified.

The intra-observer coefficient of variation for RV free-wall PSS

was 7% with a mean difference

±

SD of 0.4

±

2.7 (

p

=

0.5), and

for LVGLS it was 2.4% with a mean difference

±

SD of 1.1

±

2.7

(

p

=

0.09). The inter-observer variability coefficient was 7.6% for

RV free-wall PSS with a mean difference

±

SD of 0.5

±

3.8 (

p

=

0.5) and for LVGLS it was 9.8% with a mean difference

±

SD of

0.25

±

2.4 (

p

=

0.6).

Fig. 1.

Reduced RV free-wall peak systolic strain (PSS) in a chronic rheumatic mitral regurgitation patient (left) compared to normal

RV free-wall PSS in a control subject (right).

Table 2. Echocardiographic parameters of the study population

Variable

CRMR patients

(

n

=

77)

Controls

(

n

=

40)

p

-value

LV parameters

EDD (mm)

54.8

±

9.4

42.5

±

4.8

<

0.0001

ESD (mm)

41.4

±

9.4

27.1

±

4.2

<

0.0001

LVPWD (mm)

8.5

±

1.5

9.2

±

1.9

0.03

EDVi (ml/m

2

)

93.2

±

30.1

47.9

±

13.5

<

0.0001

ESVi (ml/m

2

)

40.0

±

22.2

17.8

±

6.4

<

0.0001

LAVi (ml/m

2

)

64.1

±

39.9

21.9

±

4.9

<

0.0001

EF (%)

58.5

±

12.9

62.8

±

11.2

0.07

LVMi (kg/m

2

)

102.7

±

36.3

65.6

±

20.3

<

0.0001

E wave (cm/s)

133.8

±

48.1

77.0

±

17.6

<

0.0001

A wave (cm/s)

98.4

±

33.5

59.6

±

13.0

<

0.0001

E

medial (cm/s)

7.3

±

2.3

8.8

±

2.8

0.002

E

lateral (cm/s)

10.1

±

4.0

13.4

±

3.6

<

0.0001

E/E

medial (cm/s)

20.1

±

10.7

9.4

±

3.0

<

0.0001

E/E

lateral (cm/s)

15.4

±

8.8

5.9

±

1.6

<

0.0001

S

medial (cm/s)

6.3

±

1.3

7.1

±

1.6

0.004

S

lateral (cm/s)

7.3

±

2.5

8.2

±

2.6

0.07

LV GLS (%)

–16.1

±

5.3

–17.9

±

2.1

0.04

RV parameters

RV base (mm)

32.1

±

6.9

30.8

±

4.7

0.28

RVS

(cm/s)

11.5 (9.7–13.8) 11.6 (10.5–13.4)

0.29

TAPSE (cm)

2.1

±

0.4

2.2

±

3.2

0.78

RAVi (ml/m

2

)

23.1

±

12.9

18.6

±

5.4

0.03

TR (grade

2+ TR) (%)

30%

PASP (mmHg)

35.1

±

16.9

22.1

±

5.6

<

0.0001

RV free-wall PSS (%)

–16.8

±

4.5

–19.2

±

3.4

0.003

Data are presented as mean

±

SD or %.

Values are indexed to BSA.

CRMR, chronic rheumatic mitral regurgitation; EDVi, end-diastolic volume

indexed; ESVi, end-systolic volume indexed; IVSD, interventricular septal

diameter; LAVi, left atrial volume indexed; EDD, end-diastolic diameter; EF,

ejection fraction; ESD, end-systolic diameter; GLS, global longitudinal strain;

LV, left ventricle; LVMi, left ventricular mass indexed; NYHA, New York Heart

Association; PASP, pulmonary artery systolic pressure; PWD, posterior wall

diameter; PSS, peak systolic strain; RAVi, right atrial volume indexed; RV, right

ventricle; TAPSE, tricuspid annular plane systolic excursion.

Table 3. RV systolic function parameters according to severity of MR

Variable

Moderate CRMR

(

n

=

51)

Severe CRMR

(

n

=

26)

p-

value

RV wall thickness (mm)

5.9

±

1.6

7.2

±

2.3

0.006

PASP (mmHg)

31.0

±

12.3

43.9

±

21.3

0.001

RVS

(cm/s)

11.6 (9.9–14.6)

11.4 (9.4–13.4)

0.29

TAPSE (cm)

2.1

±

0.38

2.0

±

0.4

0.28

RV free-wall PSS (%)

–17.7

±

4.2

–15

±

4.7

0.01

Data are presented as median (IQR), mean

±

SD. CRMR, chronic rheumatic

mitral regurgitation; PASP, pulmonary artery systolic pressure; PSS, peak

systolic strain; RV, right ventricle; TAPSE, tricuspid annular plane systolic

excursion.